253 related articles for article (PubMed ID: 11977454)
21. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
22. COX-2 inhibitors: better than ibuprofen for dental pain?
Dionne R
Compend Contin Educ Dent; 1999 Jun; 20(6):518-20, 522-4. PubMed ID: 10650365
[No Abstract] [Full Text] [Related]
23. Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
Chau I; Cunningham D
N Engl J Med; 2002 Apr; 346(14):1085-7. PubMed ID: 11932478
[No Abstract] [Full Text] [Related]
24. [COX-2 inhibitors: a new treatment in rheumatic diseases].
Puddu G; Cravero E
Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282
[TBL] [Abstract][Full Text] [Related]
25. Tolerability of cyclooxygenase 2 inhibitors and the advisability of oral challenge.
Rodríguez M; Enrique E; Castello JV; de Mateo JA; Roca B; Malek T
Ann Allergy Asthma Immunol; 2003 Dec; 91(6):589. PubMed ID: 14700447
[No Abstract] [Full Text] [Related]
26. NSAIDs to prevent colorectal cancer: a question of sensitivity.
Elder DJ; Paraskeva C
Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741
[No Abstract] [Full Text] [Related]
27. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group.
Dahlén B; Szczeklik A; Murray JJ;
N Engl J Med; 2001 Jan; 344(2):142. PubMed ID: 11188419
[No Abstract] [Full Text] [Related]
28. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
Kismet K; Akay MT; Abbasoglu O; Ercan A
Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
[TBL] [Abstract][Full Text] [Related]
29. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
30. Overview of nimesulide.
Bennett A
Rheumatology (Oxford); 1999 May; 38 Suppl 1():1-3. PubMed ID: 10369398
[No Abstract] [Full Text] [Related]
31. [A new class of nonsteroidal anti-inflammatory agents: COXIBs].
Costantino S
Clin Ter; 2003; 154(1):5-6. PubMed ID: 12854276
[No Abstract] [Full Text] [Related]
32. Cyclooxygenase inhibition in patients with coronary artery disease.
Frishman WH
J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
[No Abstract] [Full Text] [Related]
33. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Jüni P; Rutjes AW; Dieppe PA
BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
[No Abstract] [Full Text] [Related]
34. [Therapeutic advances with coxibs: few certainties and a lot of doubts].
Jouzeau JY; Daouphars M; Netter P
Therapie; 2004; 59(2):207-11. PubMed ID: 15359614
[No Abstract] [Full Text] [Related]
35. COX-1 sparing and COX-2 inhibitory drugs: the renal and hepatic safety and tolerability profiles of celecoxib.
Whelton A
Am J Ther; 2000 May; 7(3):151-2. PubMed ID: 11317163
[No Abstract] [Full Text] [Related]
36. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
He W; Liu CF; Huang CQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
[TBL] [Abstract][Full Text] [Related]
37. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
Vanchieri C
J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
[No Abstract] [Full Text] [Related]
38. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
Liao Z; Milas L; Komaki R; Stevens C; Cox JD
Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
[TBL] [Abstract][Full Text] [Related]
39. COX-2-Selective NSAIDs: new and improved?
Lichtenstein DR; Wolfe MM
JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
[No Abstract] [Full Text] [Related]
40. Visual disturbance associated with celecoxib.
Lund BC; Neiman RF
Pharmacotherapy; 2001 Jan; 21(1):114-5. PubMed ID: 11191731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
